1 Auditing and Monitoring Gerald Beccia/RCO VA CT Healthcare System.

Slides:



Advertisements
Similar presentations
The Role of the IRB An Institutional Review Board (IRB) is a review committee established to help protect the rights and welfare of human research subjects.
Advertisements

Managing Compliance Related to Human Subjects Research Review Joseph Sherwin, Ph.D. Office of Regulatory Affairs University of Pennsylvania Fourth Annual.
CROMS NIDCR Clinical Monitoring
Tips to a Successful Monitoring Visit
Gerald Treiman, IRB Chair John Stillman, IRB Director Maureen Brinkman, IRB Administrator Ann Johnson, IRB Administrator.
Common Mistakes & Audits 05/21/2014. Summary of audit findings by category.
Audit Ebru Mutlu-Omega CRO. General Purpose to help quality (to maintain quality at present) to assure quality (make sure that quality in future is maintained)
RESEARCH COMPLIANCE Agenda 1. No Destruction of local research documents after scanning 2. Training for shipping biological samples/specimens 3. Regulatory.
UTHSC IRB Donna Hollaway, RN, CCRC 11/30/2011 Authority to Audit 45 CFR (e) An IRB shall conduct continuing review of research covered by this.
Common Errors to avoid in IRB- 03 (VA) Applications.
Division of Women’s Health Quality Assurance / Quality Improvement Process February 21, 2013.
IRB Determinations 1. AAHRPP Site Visit Results Site visitors observed a real commitment to human subject protections Investigator and research staff.
POST APPROVAL MONITORING AND EDUCATION PROGRAM Jane Lehmbeck 1, Sarah Blackman 1, Karen Davenport 2, Karen Parks 1 Office of the Vice President for Research.
Pharmacists Responsibilities in Clinical Studies Mike R Sather, PhD Crystal L Harris, PharmD February 26, 2004.
CUMC IRB Investigator Meeting Human Subjects Research Non-Compliance September 15, 2005.
Human Research Protection Program Training: Post-Approval Event Reporting March 26, 2008 Lisa Voss, MPH, CIP Assistant Director, QIU Human Research Protection.
Brookhaven Science Associates U.S. Department of Energy 1 Brookhaven National Laboratory Protocol Compliance Monitoring Darcy Mallon May 7, 2009.
HRPP Policies & Forms Created/Revised for AAHRPP.
FPSC Safety, LLC ISO AUDIT.
Internal Auditing in Research: The QA Process Research Education Series February 14, 2011 Sarah Dutkevitch, RN, OCN, Clinical Research Nurse Specialist.
Continuing Review VA Requirements Kevin L. Nellis, M.S., M.T. (A.S.C.P.) Program Analyst Program for Research Integrity Development and Education (PRIDE)
Federalwide Assurance Presentation for IRB Members.
International Research & Research Involving Children K. Lynn Cates, MD Assistant Chief Research & Development Officer Office of Research & Development.
Adverse Events and Unanticipated Problems Presented by: Karen Jeans, PhD, CCRN, CIP COACH Program Analyst.
Elements of Clinical Trial Quality Assurance Regulatory Coordinator –SCTR SUCCESS Center QA Monitor – NIDA Clinical Trials Network Stephanie Gentilin,
Office of Research Oversight ORO Reporting Adverse Events in Research to ORO Paula Squire Waterman, MS, CIP Department of Veterans Affairs Office of Research.
Common Audit Findings UTHSC Institutional Review Board (IRB)
RESCUE: ACRIN 4701 Protocol Development & Regulatory Compliance (PDRC) Josephine Schloesser, ACRIN Monitor Chris Steward, ACRIN QC Auditor.
Preparing For A VA Compliance Audit Kimberly Summers, PharmD Assistant Chief for Clinical Research South Texas Veterans Health Care System, San Antonio,
Michelle Groy Johnson Quality Improvement Officer Research Integrity Office Tough Love: Understanding the Purpose and Processes of Quality Assurance.
Research Auditing Presented by: Darlene Krueger, MBA RN CCRA Chief, GCP Auditing & Training VA Cooperative Studies Program Albuquerque, NM.
Monitoring IRB Monitoring of Clinical Trials. Types of Monitoring Internally Internally Externally Externally.
Ensuring Human Subject Protection A Guide for Those who Obtain Research Informed Consent Documents 10/15/20151.
Research Studies GOTCHA’S By Sally Duffy. Failure to follow protocol, investigator agreements and regulations Did not use device/drug in manner specified.
Questions: AAHRPP Evaluation Instrument for Use with Final Revised Accreditation Standards Presented by: C. Karen Jeans, MSN, CCRN, CIP COACH Program Analyst,
Office of Research Oversight 1 VHA Handbook Research Compliance Reporting Requirements Revised May 21, 2010 (Presentation prepared for HRPP 101,
VHA Handbook “Research Compliance Reporting Requirements” Version: June 15, 2015 ORO Presentation: July 14 and 16, 2015.
Office of Research & Development (ORD) Local Accountability of Research 2009 Baltimore, Maryland January 13-14, 2009 “Meeting the Current Challenges of.
Human Research Protection Program & IRB Responsibilities Marisue Cody, PhD Director Center on Advice & Compliance Help.
AUDIT REQUIREMENTS, FINDINGS & BASICS RESEARCH COMPLIANCE.
VHA Handbook What’s new. General Requirements for Informed Consent A Legally Authorized Representative may not always qualify as a ‘personal representative’
OBSERVED IN ORO REVIEWS COMPLIANCE ISSUES: OBSERVED IN ORO REVIEWS David A. Weber, Ph.D., FACNP Acting Chief Officer Office of Research.
Continuing Review Presented by: Karen Jeans, PhD, CCRN, CIP Program Analyst, COACH.
VHA Research Compliance Reporting Requirements ORD Accreditation Conference Call December 15, 2011.
Post-Approval Monitoring (PAM) Program November 17, 2015.
The NCI Central IRB Initiative Jacquelyn L. Goldberg, J.D. VA IRB Chair Training April 8, 2004.
HRPP Policies & Forms Chapter Two Created/Revised for AAHRPP June 1, 2007.
CTMB Guidelines (Rev. October 2006) Section 5: Conducting the Quality Assurance Audit.
Office of Research Oversight 1 Office of Research and Development Local Accountability Meeting January 2009.
RIHES-II: H ANDLING A UDITS AND I NSPECTIONS E FFECTIVE D ATE 25 D ECEMBER 2006 V ERSION : 3.0 บุญเหลือ พรึงลำภู 15 มกราคม 2557.
Office of Human Research Protection Georgia Health Sciences University.
Conducting Research at Lincoln IRB/HRPP Policies, Procedures & Good Clinical Practices B Kanna MD, MPH, FACP Associate Program Director of Internal Medicine.
Sponsor Visits and Monitoring
VA HRPP Accreditation October 18, 2011 Accreditation Conference Call PRIDE/Soundia Duche, MA, MS.
Office of Research & Development (ORD) Local Accountability of Research 2009 Baltimore, Maryland January 13-14, 2009 “Meeting the Current Challenges of.
Office of Research Oversight What’s New in VHA Handbook Dated November 15, 2011 December 1, 2011.
CONDUCTING COMPLIANCE ASSESSMENTS Allen Ditch Director Corporate Quality Bristol Myers Squibb Medical Research Summit March 6, 2003.
Marianne M. Elliott Office of Research Integrity and Ethics Bureau of Medicine and Surgery U. S Navy.
Korea Food & Drug Administration Deputy director Kwang-Soo Joo Korea FDA Sep. 29, 2000 : Korean Good Clinical Practice & Relative Guidelines How to Manage.
Slide 1 Standard Operating Procedures. Slide 2 Goal To review the standard operating procedures Creating the informed consent document Obtaining informed.
HRPP METRICS Cynthia Monahan, MBA, CIP IRB Director Boston University Charles River Campus IRB.
Sponsor Visits and Monitoring Barbara Gallagher, RN Clinical Research Nurse Jefferson Clinical Research Institute.
Reasons for Auditing There are many reasons for auditing. Some examples of these reasons might be: Requested by the IRB Committee Requested by an IRB.
Jeffrey M. Cohen, Ph.D. CIP President HRP Associates, Inc.
AAHRPP + IRB Update Michael Mahoney
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
Navigating Non-Compliance
Event Reporting in Human Subjects Research
Protocol Approval Criteria
Good clinical practice
Presentation transcript:

1 Auditing and Monitoring Gerald Beccia/RCO VA CT Healthcare System

2 Presentation Overview Responsibility and Authority Choosing Indicators Protocol Audits –Types of Protocol Audits –Choosing Protocols –Audit Preparation –Audit Process –Follow-up QA vs. QI

3 Responsibility VHA Handbook Paragraph 5 – MEDICAL CENTER DIRECTOR RESPONSIBILITES Section a(5) - Every Medical Center Director is responsible for developing and monitoring procedures to ensure the safety of subjects in research either directly or by delegating the responsibility to other qualified VA staff.

4 Authority VHA Handbook Paragraph 7 – IRB RESPONSIBILITES AND AUTHORITY Section e - AUDITING RECURRING PROCESSES 1.Conduct audits of recurring processes to be sure that all written procedures are followed 2.Review research records and research case histories for compliance with written procedures and regulations contained in this Handbook 3.Monitor the informed consent process and the research, and 4.Consider results of audits conducted by other entities within the institution

5 It’s an unfortunate fact of life that there are many things that can put research subjects at risk and literally dozens of items that can get you into serious trouble with literally dozens of organizations What to audit?

6 What to Audit? (things to consider) Audit Motivation Auditor’s Skills and Competencies Organizational Vulnerabilities Regulatory Hot Spots What data is already “out there” and available for your use.

7 What to Audit? (things to remember) Audits should encompass as many components of the HRPP program as possible Variability is a Virtue (broadens the scope and lessens the boredom )

8 Protocol Audits Types of Audits Choosing Protocols Preparation The Audit Process Follow-ups

9 Protocol Audits (types of audits) For Cause Audits –RCO –ACOS/R –Medical Center Director –IRB Chair Random Audits –RCO

10 Protocol Audits (choosing protocols) High or Moderate Risk Vulnerable Subjects Enrollment Status –Actively enrolling –Currently enrolling PI Experience & History

11 Protocol Audits (preparation) ● Get access to and learn how to use CPRS ● Know your protocol history Decide in advance what protocol specific items you will be looking for Develop a protocol specific audit tool Do as much as possible in advance, i.e. from your desk using CPRS (leaves far more time for discussion and education)

12 Protocol Audits (the process) Notification and Scheduling ● Preliminary Briefing Audit ● PI Notification – Response expected ● Written Report -To: Medical Center Director - cc: IRB/R&D ● Verbal Summary of Report at IRB Meeting ● Copy of Report to PI

13 PI Study # Title Initial HSS Appr Last CR Date Ref Dates # Enrolled # Files Reviewed 10/21/049/15/05Sep 05 – May /1/041/19/06Jan 06 – May /21/05NAJul 05 – May 0633 Background Information

14 PI Study # Title Reporting of all AEs Reporting of all Deviations Adherence to Protocol Compliance w/ Inclusion/Exclusion Criteria Met Not Met 1 Met 1 “ …………………………..” AEs, Deviations, Inclusion/Exclusion Criteria, Adherence to Protocol

15 Protocol Audits (what I review) Consent Forms Research Alerts Adverse Events Deviations/Adherence to Protocol Inclusion/Exclusion Criteria

16 Follow-up Reports Every six months (approximately) Focus on events or issues identified in previous audits Purpose: –Assure that PI action items were completed –Assure that interventions established to correct errors or omissions were effective

17 Responsibility VHA Handbook Paragraph 7 – IRB RESPONSIBILITES AND AUTHORITY Section d - Maintaining Written Procedures for Operations Bullet #9 - The IRB must establish written procedures for conducting audits of protocols and other IRB activities

18 QA vs. QI AAHRPP element I.3.L – The organization implements a plan to measure and improve HRPP effectiveness, quality 1, and compliance with organizational policies 2 and procedures and applicable federal, state, or local laws. 1 = QI2 = QA AAHRPP Commentary:

19 Gerald Beccia/RCO VA Connecticut Healthcare Tel: (203) ext

20 ?

21